We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
A new world is possible. Let's not go back to what wasn't working anyway.
Add this topic to your myFT Digest for news straight to your inbox
Scientist say AY.4.2 seems to be 10%-15% more transmissible but cannot be blamed for high UK Covid-19 case numbers
Head of Royal College of Pathologists says NHS backlog cannot be cleared without more investment in his field
Deaths and hospital admissions remain stubbornly high in Britain as the continent reports record lows
Seasonal shortages are a spur to manufacturers to invest in capacity
The neuroscientist says our perceptions have little to do with intelligence and everything to do with sensing our environment to stay alive
Panel recommends third jabs for vulnerable people in step towards expanding US rollout of extra doses
Deaths from TB increase for first time in over a decade despite confirmed cases falling
Research leaders fear government could attempt to shelve PM’s £22bn flagship funding commitment
Personalised cancer treatments are among those being developed using a technology once distrusted by big pharma
Japanese pharma company says Medicago’s product will be cheaper to make and easier to transport
IMF warns uneven pace of immunisation raises risks of economic scarring
German biotech had suffered disappointing results after initial excitement
Molnupiravir has limitations but drugmakers should be able to build on it to create other treatments
Drugmaker seeks authorisation from FDA for oral treatment shown to prevent severe disease in vulnerable people
Experts urge caution despite Delta wave slowdown amid concerns over new variants and vaccine hesitancy
Advances by Merck and AstraZeneca raise hopes of bringing more treatments to market
Former IMF official said the divisions have undermined Kristalina Georgieva’s ability to lead
World’s largest endowment investor has only one professional manager just months before launch
Researchers are hailing a breakthrough in personalised treatments for mental illness that could be used for other conditions
September data fall short of expectations and suggest rebound in growth is slowing
Workers rush to leave Vietnam trading hub after coronavirus restrictions lifted
GlaxoSmithKline jab recommended for use in Sub-Saharan Africa and other regions at risk
‘In some ways, the pandemic ought to make us all feel more upbeat about the long-term future of medical research’
Equity issue will help pay off more than €4bn in state-backed loans taken during worst of pandemic
Central bank increases lending rate to 0.5% despite Covid lockdown in Auckland
International Edition
